Regional research priorities in brain and nervous system disorders

Nature

Volumn 527, Issue 7578, 2015, Pages E198-E206

  Ravindranath, Vijayalakshmi ^a   Dang, Hoang Minh ^b   Goya, Rodolfo G ^c   Mansour, Hader ^d,e   Nimgaonkar, Vishwajit L ^f   Russell, Vivienne Ann ^g   Xin, Yu ^h  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e MANSOURA UNIVERSITY   (Egypt)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h PEKING UNIVERSITY SIXTH HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CULTURE; DEMOGRAPHY; EPIDEMIOLOGY; GENETICS; INFECTIOUS DISEASE; LAND USE; LIFESTYLE; LONGEVITY; NERVOUS SYSTEM DISORDER; NEUROLOGY; POPULATION SIZE; POVERTY; RESEARCH WORK; RISK FACTOR; SOCIAL CONFLICT;

AFRICA SOUTH OF THE SAHARA; ASIA; BRAIN DISEASE; BRAIN PROTECTION; CARIBBEAN; HUMAN; MIDDLE EAST; NEUROLOGIC DISEASE; NORTH AFRICA; PRIORITY JOURNAL; RESEARCH PRIORITY; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; SCIENTIST; SOUTH AND CENTRAL AMERICA; DEVELOPING COUNTRY; GENETICS; HEALTH CARE PLANNING; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; SUBSTANCE-RELATED DISORDERS;

MIDDLE EAST; NORTH AFRICA; SUB-SAHARAN AFRICA;

BIOMEDICAL RESEARCH; DEVELOPING COUNTRIES; HEALTH RESOURCES; HUMANS; INTERNATIONALITY; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; SUBSTANCE-RELATED DISORDERS;

EID: 84947591897     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature16036     Document Type: Review

References (119)

1. Murray, C. J. et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197-2223 (2012).
2. Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743-800 (2015).
3. Murray, C. J., Lopez, A. D. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet 349, 1347-1352 (1997).
4. Whiteford, H. A. et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382, 1575-1586 (2013).
5. Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., Vos, T. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PLoS ONE 10, e0116820 (2015).
6. Kerac, M. et al. The interaction of malnutrition and neurologic disability in Africa. Semin. Pediatr. Neurol. 21, 42-49 (2014).
7. Degenhardt, L., Whiteford, H., Hall, W. D. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease Drug Alcohol Rev. 33, 4-12 (2014).
8. Hess, A. T. et al. A comparison of spectral quality in magnetic resonance spectroscopy data acquired with and without a novel EPI-navigated PRESS sequence in school-aged children with fetal alcohol spectrum disorders. Metab. Brain Dis. 29, 323-332 (2014).
9. Kwiatkowski, M. A., Roos, A., Stein, D. J., Thomas, K. G., Donald, K. Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies. Metab. Brain Dis. 29, 245-254 (2014).
10. Odenwald, M. in Neglected Tropical Disease and Conditions of the Nervous System (eds Bentivoglio, M. et al.) 293-306 (Springer, 2014).
11. Patel, N. B. in Neglected Tropical Disease and Conditions of the Nervous System (eds Bentivoglio, M. et al.) 307-320 (Springer, 2014).
12. Njuguna, J., Olieva, S., Muruka, C., Owek, C. Khat consumption in Masalani town, northeastern Kenya. J. Psychoactive Drugs 45, 355-359 (2013).
13. Warfa, N. et al. Khat use and mental illness: a critical review. Soc. Sci. Med. 65, 309-318 (2007).
14. Ba-Diop, A. et al. Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa. Lancet Neurol. 13, 1029-1044 (2014).
15. Mustapha, A. F., Preux, P. M., Sanya, E. O., Akinleye, C. A. The prevalence and subjective handicap of epilepsy in Ilie-a rural riverine community in South West Nigeria: a door-to-door survey. Epilepsy Behav. 37, 258-264 (2014).
16. Ngugi, A. K. et al. Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol. 12, 253-263 (2013).
17. Osakwe, C., Otte, W. M., Alo, C. Epilepsy prevalence, potential causes and social beliefs in Ebonyi State and Benue State, Nigeria. Epilepsy Res. 108, 316-326 (2014).
18. Wagner, R. G. et al. Prevalence and risk factors for active convulsive epilepsy in rural northeast South Africa. Epilepsy Res 108, 782-791 (2014).
19. Wilmshurst, J. M., Birbeck, G. L., Newton, C. R. Epilepsy is ubiquitous, but more devastating in the poorer regions of the world. or is it Epilepsia 55, 1322-1325 (2014).
20. Lekoubou, A., Nkoke, C., Dzudie, A., Kengne, A. P. Stroke admission and case-fatality in an urban medical unit in sub-Saharan Africa: a fourteen year trend study from 1999 to 2012. J. Neurol. Sci. 350, 24-32 (2015).
21. Kalaria, R. N. et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 7, 812-826 (2008).
22. Mavrodaris, A., Powell, J., Thorogood, M. Prevalences of dementia and cognitive impairment among older people in sub-Saharan Africa: a systematic review. Bull. World Health Organ. 91, 773-783 (2013).
23. Sepulveda, J., Murray, C. The state of global health in 2014. Science 345, 1275-1278 (2014).
24. Laughton, B., Cornell, M., Boivin, M., Van Rie, A. Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J. Int. AIDS Soc. 16, 18603 (2013).
25. Birbeck, G. L. et al. Neuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural Zambia. Am. J. Trop. Med. Hyg. 85, 782-789 (2011).
26. Hoare, J. et al. Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents. Metab. Brain Dis. 29, 221-229 (2014).
27. Ferrari, A. J. et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 10, e1001547 (2013).
28. Alhasnawi, S. et al. The prevalence and correlates of DSM-IV disorders in the Iraq Mental Health Survey (IMHS). World Psychiatry 8, 97-109 (2009).
29. Espie, E. et al. Trauma-related psychological disorders among Palestinian children and adults in Gaza and West Bank, 2005-2008. Int. J. Ment. Health Syst. 3, 21 (2009).
30. Al-Gazali, L., Hamamy, H. Consanguinity and dysmorphology in Arabs. Hum. Hered. 77, 93-107 (2014).
31. Al-Gazali, L., Hamamy, H., Al-Arrayad, S. Genetic disorders in the Arab world. Br. Med. J. 333, 831-834 (2006).
32. Tadmouri, G. O., Al Ali, M. T., Al-Haj Ali, S., Al Khaja, N. CTGA: the database for genetic disorders in Arab populations. Nucleic Acids Res. 34, D602-D606 (2006).
33. Hamdi, E. et al. Lifetime prevalence of alcohol and substance use in Egypt: a community survey. Subst. Abus. 34, 97-104 (2013).
34. Preux, P. M., Druet-Cabanac, M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol. 4, 21-31 (2005).
35. Benamer, H. T., Grosset, D. G. A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia 50, 2301-2304 (2009).
36. Mirkin, B. Population Levels, Trends and Policies in the Arab Region: Challenges and Opportunities. Arab Human Development Report http://mait.camins.cat/ET2050-library/docs/med/arab-population.pdf. (United Nations Development Programme, 2010).
37. Thomas, S. V., Nair, A. Confronting the stigma of epilepsy. Ann. Indian Acad. Neurol. 14, 158-163 (2011).
38. Fleitlich-Bilyk, B., Goodman, R. Prevalence of child and adolescent psychiatric disorders in southeast Brazil. J. Am. Acad. Child Adolesc. Psychiatry 43, 727-734 (2004).
39. Duarte, C. et al. Child mental health in Latin America: present and future epidemiologic research. Int. J. Psychiatry Med. 33, 203-222 (2003).
40. Rodriguez, A. et al. Is prenatal alcohol exposure related to inattention and hyperactivity symptoms in children Disentangling the effects of social adversity. J. Child Psychol. Psychiatry 50, 1073-1083 (2009).
41. World Health Organization. Global Status Report on Alcohol and Health http://apps. who.int/iris/bitstream/10665/112736/1/9789240692763-eng.pdf (WHO, 2014).
42. Borges, G. et al. Alcohol and violence in the emergency department: a regional report from the WHO collaborative study on alcohol and injuries. Salud Publica Mex. 50 (Suppl 1), S6-S11 (2008).
43. Massey, J. S., Meares, S., Batchelor, J., Bryant, R. A. An exploratory study of the association of acute posttraumatic stress, depression, and pain to cognitive functioning in mild traumatic brain injury. Neuropsychology 29, 530-542 (2015).
44. Burneo, J. G., Tellez-Zenteno, J., Wiebe, S. Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res. 66, 63-74 (2005).
45. Bruno, E. et al. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl. Trop. Dis. 7, e2480 (2013).
46. Nitrini, R. et al. Prevalence of dementia in Latin America: a collaborative study of population-based cohorts. Int. Psychogeriatr. 21, 622-630 (2009).
47. Prince, M. et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 9, 63-75 (2013).
48. Mejia, S., Giraldo, M., Pineda, D., Ardila, A., Lopera, F. Nongenetic factors as modifiers of the age of onset of familial Alzheimer's disease. Int. Psychogeriatr. 15, 337-349 (2003).
49. Paradisi, I., Hernandez, A., Arias, S. Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation. J. Hum. Genet. 53, 127-135 (2008).
50. Pastor, P. et al. Apolipoprotein E4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann. Neurol. 54, 163-169 (2003).
51. Feigin, V. L. et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 383, 245-254 (2014).
52. Mac, T. L. et al. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol. 6, 533-543 (2007).
53. Alzheimer's Disease International. World Alzheimer Report 2009: The Global Prevalence of Dementia http://www.alz.co.uk/research/world-report-2009 (ADI, 2009).
54. Shaji, S., Bose, S., Verghese, A. Prevalence of dementia in an urban population in Kerala, India. Br. J. Psychiatry 186, 136-140 (2005).
55. Mehndiratta, M. M., Khan, M., Mehndiratta, P., Wasay, M. Stroke in Asia: geographical variations and temporal trends. J. Neurol. Neurosurg. Psychiatry 85, 1308-1312 (2014).
56. Kulshreshtha, A., Anderson, L. M., Goyal, A., Keenan, N. L. Stroke in South Asia: a systematic review of epidemiologic literature from 1980 to 2010. Neuroepidemiology 38, 123-129 (2012).
57. Wasay, M., Khatri, I. A., Kaul, S. Stroke in South Asian countries. Nature Rev. Neurol. 10, 135-143 (2014).
58. Xu, G., Ma, M., Liu, X., Hankey, G. J. Is there a stroke belt in China and why Stroke 44, 1775-1783 (2013).
59. Mackay, J., Ritthiphakdee, B., Reddy, K. S. Tobacco control in Asia. Lancet 381, 1581-1587 (2013).
60. Dans, A. et al. The rise of chronic non-communicable diseases in southeast Asia: time for action. Lancet 377, 680-689 (2011).
61. Uthman, O. A. et al. Increasing the value of health research in the WHO African Region beyond 2015-reflecting on the past, celebrating the present and building the future: a bibliometric analysis. BMJ Open 5, e006340 (2015).
62. Razzouk, D. et al. Scarcity and inequity of mental health research resources in low-and-middle income countries: a global survey. Health Policy 94, 211-220 (2010).
63. Sharan, P. et al. Mental health research priorities in low-and middle-income countries of Africa, Asia, Latin America and the Caribbean. Br. J. Psychiatry 195, 354-363 (2009).
64. Okasha, A., Karam, E., Okasha, T. Mental health services in the Arab world. World Psychiatry 11, 52-54 (2012).
65. Goel, D. S., Agarwal, S. P., Icchpujani, R. L., Shrivastava, S. in Mental Health: An Indian Perspective, 1946-2003 (eds S.P. Agarwal et al.) 3-24 (Directorate General of Health Services/Ministry of Health and Family Welfare, 2004).
66. Seedat, S. et al. Twelve-month treatment of psychiatric disorders in the South African Stress and Health Study (World Mental Health Survey Initiative). Soc. Psychiatry Psychiatr. Epidemiol. 43, 889-897 (2008).
67. World Health Organization. Atlas: Country Resources for Neurological Disorders http://www.who.int/mental-health/neurology/neurogy-atlas-lr.pdf (WHO, 2004).
68. Saxena, S., Paraje, G., Sharan, P., Karam, G., Sadana, R. The 10/90 divide in mental health research: trends over a 10-year period. Br. J. Psychiatry 188, 81-82 (2006).
69. Pang, T., Lansang, M. A., Haines, A. Brain drain and health professionals. Br. Med. J. 324, 499-500 (2002).
70. Padma, T. V. Developing countries: the outcomes paradox. Nature 508, S14-15 (2014).
71. Dorsey, E. R. et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68, 384-386 (2007).
72. Paddick, S. M. et al. Dementia prevalence estimates in sub-Saharan Africa: comparison of two diagnostic criteria. Glob. Health Action 6, 19646 (2013).
73. Yang, G. et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 381, 1987-2015 (2013).
74. Irving, J. A., Segal, Z. V. Mindfulness-based cognitive therapy: current status and future applications. Sante Ment. Que. 38, 65-82 (2013).
75. Kabat-Zinn, J. et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am. J. Psychiatry 149, 936-943 (1992).
76. Linehan, M. M. Dialectical behavior therapy for borderline personality disorder. Theory and method. Bull. Menninger. Clin. 51, 261-276 (1987).
77. Manjunath, R. B., Varambally, S., Thirthalli, J., Basavaraddi, I. V., Gangadhar, B. N. Efficacy of yoga as an add-on treatment for in-patients with functional psychotic disorder. Indian J. Psychiatry 55, S374-S378 (2013).
78. Rao, N. P., Varambally, S., Gangadhar, B. N. Yoga school of thought and psychiatry: Therapeutic potential. Indian J. Psychiatry 55, S145-149 (2013).
79. Knudsen, E. I., Heckman, J. J., Cameron, J. L., Shonkoff, J. P. Economic, neurobiological, and behavioral perspectives on building America's future workforce. Proc. Natl Acad. Sci. USA 103, 10155-10162 (2006).
80. Bain, L. E. et al. Malnutrition in Sub-Saharan Africa: burden, causes and prospects. Pan. Afr. Med. J. 15, 120 (2013).
81. Motadi, S. A., Mbhenyane, X. G., Mbhatsani, H. V., Mabapa, N. S., Mamabolo, R. L. Prevalence of iron and zinc deficiencies among preschool children ages 3 to 5 y in Vhembe district, Limpopo province, South Africa. Nutrition 31, 452-458 (2015).
82. Said-Mohamed, R., Micklesfield, L. K., Pettifor, J. M., Norris, S. A. Has the prevalence of stunting in South African children changed in 40 years A systematic review. BMC Public Health 15, 534 (2015).
83. Black, R. E. et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 382, 427-451 (2013).
84. Kitsao-Wekulo, P. et al. Nutrition as an important mediator of the impact of background variables on outcome in middle childhood. Front. Hum. Neurosci. 7, 713 (2013).
85. Nzwalo, H., Cliff, J. Konzo: From poverty, cassava, and cyanogen intake to toxico-nutritional neurological disease. PLoS Negl. Trop. Dis. 5, e1051 (2011).
86. Woldeamanuel, Y. W., Hassan, A., Zenebe, G. Neurolathyrism: two Ethiopian case reports and review of the literature. J. Neurol. 259, 1263-1268 (2012).
87. United Nations Office on Drugs and Crime. World Drug Report https://www.unodc. org/documents/wdr2014/World-Drug-Report-2014-web.pdf. (UN, 2014).
88. Watt, M. H. et al. The impact of methamphetamine ("tik") on a peri-urban community in Cape Town, South Africa. Int. J. Drug Policy 25, 219-225 (2014).
89. Schuurman, N. et al. Intentional injury and violence in Cape Town, South Africa: an epidemiological analysis of trauma admissions data. Glob. Health Action 8, 27016 (2015).
90. Hoffman, R., al'Absi, M. Working memory and speed of information processing in chronic khat users: preliminary findings. Eur. Addict. Res. 19, 1-6 (2013).
91. Duggan, M. B. Epilepsy and its effects on children and families in rural Uganda. Afr. Health Sci. 13, 613-623 (2013).
92. Owolabi, M. O. et al. The burden of stroke in Africa: a glance at the present and a glimpse into the future. Cardiovasc. J. Afr. 26, S27-S38 (2015).
93. Lekoubou, A., Echouffo-Tcheugui, J. B., Kengne, A. P. Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review. BMC Public Health 14, 653 (2014).
94. Li, D., Zhang, D. J., Shao, J. J., Qi, X. D., Tian, L. A meta-analysis of the prevalence of depressive symptoms in Chinese older adults. Arch. Gerontol. Geriatr. 58, 1-9 (2014).
95. Ma, X., Li, S. R., Xiang, Y. Q. An epidemiological survey on depressive disorder in Beijing Aria. Chinese J. Psychiatry 40, 100-103 (2007).
96. Malhotra, S., Patra, B. N. Prevalence of child and adolescent psychiatric disorders in India: a systematic review and meta-analysis. Child Adolesc. Psychiatry Ment. Health 8, 22 (2014).
97. Saxena, S., Thornicroft, G., Knapp, M., Whiteford, H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet 370, 878-889 (2007).
98. Patel, V. The need for treatment evidence for common mental disorders in developing countries. Psychol. Med. 30, 743-746 (2000).
99. Subodh, B. N., Avasthi, A., Chakrabarti, S. Psychosocial impact of dysthymia: a study among married patients. J. Affect. Disord. 109, 199-204 (2008).
100. Chan, K. Y. et al. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet 381, 2016-2023 (2013).
101. Jitapunkul, S., Kunanusont, C., Phoolcharoen, W., Suriyawongpaisal, P. Prevalence estimation of dementia among Thai elderly: a national survey. J. Med. Assoc. Thai 84, 461-467 (2001).
102. Shaji, K. S. et al. The Dementia India Report: Prevalence, Impact, Costs and Services for Dementia http://www.alzheimer.org.in/dementia-2010.pdf. (Alzheimer's and Related Disorders Society of India, 2010).
103. Wang, G. et al. Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai, China. J. Alzheimers Dis. 15, 109-115 (2008).
104. Liu, L., Wang, D., Wong, K. S., Wang, Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 42, 3651-3654 (2011).
105. Alarcon, R. D. Mental health and mental health care in Latin America. World Psychiatry 2, 54-56 (2003).
106. Hyder, A. A., Wunderlich, C. A., Puvanachandra, P., Gururaj, G., Kobusingye, O. C. The impact of traumatic brain injuries: a global perspective. Neurorehabilitation 22, 341-353 (2007).
107. D'Souza, M. S., Markou, A. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict. Sci. Clin. Pract. 6, 4-16 (2011).
108. Pyne, H. H., Claeson, M., Correia, M. Gender Dimensions of Alcohol Consumption and Alcohol-Related Problems in Latin America and the Caribbean. World Bank Discussion paper; no. WDP 433 http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2005/04/25/000112742-20050425144138/Rendered/PDF/wdp435.pdf. (World Bank, 2002).
109. Champagne, B. M. et al. Tobacco smoking in seven Latin American cities: the CARMELA study. Tob. Control 19, 457-462 (2010).
110. Barreto, S. M. et al. Epidemiology in Latin America and the Caribbean: current situation and challenges. Int. J. Epidemiol. 41, 557-571 (2012).
111. Hyder, A. A. et al. Global childhood unintentional injury surveillance in four cities in developing countries: a pilot study. Bull World Health Organ. 87, 345-352 (2009).
112. Puvanachandra, P., Hyder, A. A. Traumatic brain injury in Latin America and the Caribbean: a call for research. Salud Publica Mex. 50 Suppl 1, S3-S5 (2008).
113. Travers, K. U., Pokora, T. D., Cadarette, S. M., Mould, J. F. Major depressive disorder in Africa and the Middle East: a systematic literature review. Expert Rev. Pharmacoecon. Outcomes Res. 13, 613-630 (2013).
114. World Health Organization. Iraq Family Health Survey Report 2006/7 http://www.who. int/mediacentre/news/releases/2008/pr02/2008-iraq-family-health-survey-report. pdf (WHO, 2007).
115. Lavi, T., Solomon, Z. Palestinian youth of the Intifada: PTSD and future orientation. J Am. Acad. Child Adolesc. Psychiatry 44, 1176-1183 (2005).
116. Bassiony, M. M. et al. Adolescent tramadol use and abuse in Egypt. Am. J. Drug Alcohol Abuse 41, 206-211 (2015).
117. Khattab, A. et al. Smoking habits in the Middle East and North Africa: results of the BREATHE study. Respir. Med. 106 (Suppl 2), S16-S24 (2012).
118. El-Zaemey, S., Heyworth, J., Fritschi, L. Qat consumption among women living in Yemen. Int. J. Occup. Environ. Med. 5, 109-111 (2014).
119. Momtazi, S., Rawson, R. Substance abuse among Iranian high school students. Curr. Opin. Psychiatry 23, 221-226 (2010).